Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-25-000736
Filing Date
2025-02-05
Accepted
2025-02-05 16:01:19
Documents
60
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR DEC 2024 sonoma_i10q-123124.htm   iXBRL 10-Q 778812
2 CERTIFICATION sonoma_ex3101.htm EX-31.1 8573
3 CERTIFICATION sonoma_ex3102.htm EX-31.2 8799
4 CERTIFICATION sonoma_ex3201.htm EX-32.1 4834
  Complete submission text file 0001683168-25-000736.txt   3957530

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE snoa-20241231.xsd EX-101.SCH 27543
6 XBRL CALCULATION FILE snoa-20241231_cal.xml EX-101.CAL 50391
7 XBRL DEFINITION FILE snoa-20241231_def.xml EX-101.DEF 90364
8 XBRL LABEL FILE snoa-20241231_lab.xml EX-101.LAB 282681
9 XBRL PRESENTATION FILE snoa-20241231_pre.xml EX-101.PRE 227298
62 EXTRACTED XBRL INSTANCE DOCUMENT sonoma_i10q-123124_htm.xml XML 486681
Mailing Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301
Business Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301 800-759-9305
Sonoma Pharmaceuticals, Inc. (Filer) CIK: 0001367083 (see all company filings)

EIN.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-33216 | Film No.: 25593142
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)